Overland Park, KS
Stem Cell Therapy clinics in Overland Park
Overland Park supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through AdventHealth Shawnee Mission and Menorah Medical Center, and stem cell practice in the area spans downtown Overland Park, Leawood border, and the 135th Street corridor. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. Kansas regulates physician practice through the State Board of Healing Arts. There is no Kansas-specific stem cell statute, so federal 21 CFR Part 1271 rules apply. The 4 Overland Park clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and Kansas State Board of Healing Arts licensure checks.
Pure Living KC
- Colon Hydrotherapy
- Arthritis Treatment
- Red Light Therapy
- Hormone Replacement Therapy (HRT)
- Stem Cell Therapy
Dr. Jesse Lopez
- Vitamin IV Therapy
- IV Therapy
- Peptide Therapy
- Hormone Replacement Therapy (HRT)
- Testosterone Replacement Therapy (TRT)
prp & stem cell therapy
- PRP Therapy
- Arthritis Treatment
- Lyme Disease Treatment
- Stem Cell Therapy
SoftWave Therapy
- Shockwave Therapy
- Arthritis Treatment
- Migraine Treatment
- TMJ Treatment
- Stem Cell Therapy
Regulatory context
A note on Kansas's stem cell therapy rules.
Kansas cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Kansas for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. Kansas's regulatory environment relies primarily on federal law and the Kansas Healing Arts Act.
-
Kansas Healing Arts Act, Kansas Statutes Annotated Chapter 65, Article 28
Establishes physician licensure and discipline through the Kansas State Board of Healing Arts, covering MDs, DOs, chiropractors, and naprapaths. -
Kansas Pharmacy Act, Kansas Statutes Annotated Chapter 65, Article 16
Regulates compounding pharmacies aligned with federal 503A and 503B standards. -
Kansas Consumer Protection Act, Kansas Statutes Annotated Chapter 50, Article 6
Empowers the Attorney General to pursue deceptive trade practice claims against providers making unsupported clinical claims.
The FDA has corresponded with Kansas providers offering cellular therapies. The Kansas State Board of Healing Arts has disciplined physicians for unprofessional conduct including misleading regenerative medicine advertising and substandard care. The Kansas Attorney General's Consumer Protection Division can pursue deceptive marketing under the Kansas Consumer Protection Act. Kansas's smaller market means enforcement is less frequent than in larger states, but federal warning letters apply nationally and Kansas clinics that source unapproved cellular products face the same regulatory exposure.